Migraine Drugs Market to Discern Steadfast Expansion During 2018-2025 | Top Players AstraZeneca, Eisai, GlaxoSmithKline & Pfizer
Increase in prevalence of migraine, rapid rise in female population, and surge in awareness among patients for migraine treatment & prevention drive the growth of the global migraine drugs market. However, the side effects of migraine drugs are expected to limit market growth. Conversely, emerging new therapies/drugs for migraine treatment and growth opportunities in the emerging nations are expected to present opportunities for market growth during the forecast period.
Request Sample Available @ https://www.alliedmarketresearch.com/request-sample/2811?utm_source=openpr&utm_medium=ss
By type, abortive medicines accounted for more than three-fourths share of the global migraine drugs market in 2017. Furthermore, by route of administration, the oral segment is anticipated to grow at the highest rate of 3.4% during the forecast period.
• Abbott Laboratories
• Allergan Plc.
• Eisai Co.Ltd.
• Endo International Plc.
• GlaxoSmithKline Plc.
• Impax Laboratories
• Johnson & Johnson
• Merck & Co.
• Pfizer Inc.
North America was the leading revenue contributor to the global market in 2017, owing to a surge in demand for better healthcare along with effective government reforms for awareness towards migraine & its prevention. However, Asia-Pacific is expected to grow at the highest CAGR of 4.4% from 2018 to 2025, due to improvements in healthcare infrastructure and rise in demand for better healthcare facilities.
KEY FINDINGS OF THE STUDY
• North America occupied a two-fifths share of the global migraine drugs market.
• Oral is anticipated to grow with the highest CAGR throughout the forecast period.
• Europe is anticipated to occupy more than one-fourth market share of the global migraine drugs market by 2025.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
Report Enquiry Available @ https://www.alliedmarketresearch.com/purchase-enquiry/2811?utm_source=openpr&utm_medium=ss
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market to Discern Steadfast Expansion During 2018-2025 | Top Players AstraZeneca, Eisai, GlaxoSmithKline & Pfizer here
News-ID: 1650814 • Views: 299
More Releases from Allied Market Research
Smart Inhalers Market is Like to Touch $1,406 Million by 2026
Smart Inhalers Market size was valued to be at $34 million in 2018 and is expected to increase during the forecast period to be at $1,406 million by 2026, registering a CAGR of 58.4% from 2019 to 2026. The inhalers segment accounted for more than half of the total market share in 2018. Smart inhalers are the small inhaler devices used for delivering several inhaled medications such as anticholinergics, glucocorticoids, and
Surgical Sutures Market On Position to Reach $5,255 Million by 2022
Surgical Sutures Market size accounted for $3,360 million in 2015, and is expected to reach $5,255 million by 2022, growing at a CAGR of 6.4% from 2016 to 2022. The sutures segment dominated the market in 2015 with more than four-fifths share. Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/1642 Global escalation in the number of hospitals, surge in the adoption of technologically advanced products, and increase in number of surgeries due
Internet of Things in Healthcare Market Like to Cross $332 Billion by 2027
The global internet of things in healthcare market was valued at $113.751 billion in 2019 and is expected to reach $332.672 billion by 2027, registering a CAGR of 13.20% from 2020 to 2027. The internet of things (IoT) is described as a network of physical devices that uses connectivity to enable the exchange of data. The internet of things in healthcare market is gaining popularity in the recent years owing
Breast Imaging Technologies Market Is Expected to Reach $4,502 Million by 2022
Breast Imaging Technologies Market Report, published by Allied Market Research, forecasts that the global breast imaging technologies market is expected to garner $4,502 million by 2022, registering a CAGR of 8.4% during the period 2016-2022.North America and Europe together accounted for over three-fourths market share in 2015. Ionizing breast imaging technology is expected to maintain its lead throughout the forecast period. The market is expected to be driven by the rise
More Releases for Migraine
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /
EpiCast Report: Migraine-Epidemiology Forecast to 2026
Migraine is characterized by recurring headaches and throbbing pain on one side of the head accompanied by nausea, vomiting, or increased sensitivity to light or smell. While most migraineurs experience episodic migraines (EM), a small percentage suffers from chronic migraine (CM). In addition to its debilitating pain, migraines are also associated with more severe cardiovascular and neuropsychological comorbidities. Because migraine is one of the most prevalent types of headache, there
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Migraine Market: Industry Analysis & Outlook 2021
Migraine is a chronic neurovascular disorder characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks. They are quite different from regular headaches which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional challenges, alcohol exposure, diet, and hormonal cycles/changes, among others. Migraine